Concepedia

Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis

Helena Hong Wang, Ellen C. de Heer, Jan Binne Hulshoff, Gürsah Kats‐Ugurlu, Johannes G. M. Burgerhof, Boudewijn van Etten, John Th. M. Plukker, Geke A.P. Hospers

Annals of Surgical Oncology · 2020 · 14 citations · 16 references

DOIFull text

Open access

References

16

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge, Carolyn C. Compton · Annals of Surgical Oncology · 2010 · 9.1K citations · Full text

, , +7

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot et al. · New England Journal of Medicine · 2012 · 5.3K citations · Full text

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.5K citations

, , +9

The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

Harry D. Bear, Stewart Anderson, Ann Brown et al. · Journal of Clinical Oncology · 2003 · 1.1K citations

Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation

Lucian R. Chirieac, Stephen G. Swisher, Jaffer A. Ajani et al. · Cancer · 2005 · 484 citations · Full text